← Open Payments lookup

CARLY HAZZARD ANDREWS: Open Payments

NPI 1194211094 · CLEVELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$530 in 26 payments from 9 companies in 2025. Trend: 2023 $268 · 2024 $467 · 2025 $530

Food & beverage: $530
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP11$202
Novartis Pharmaceuticals Corporation4$112
ABBVIE INC.2$61
Novo Nordisk Inc2$36
Boehringer Ingelheim Pharmaceuticals, Inc.2$35
Amgen Inc.2$29
Corcept Therapeutics1$22
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19
Lilly USA, LLC1$14

Products named: AIRSUPRA, LEQVIO, LINZESS, VRAYLAR, OTEZLA, Korlym, CAPLYTA, FARXIGA.

Industry payments across MS — which companies pay providers there.